These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2371806)
1. Malignant hyperthermia: how important after 30 years. Ellis FR Acta Anaesthesiol Belg; 1990; 41(2):61-3. PubMed ID: 2371806 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing? Robinson RL; Anetseder MJ; Brancadoro V; van Broekhoven C; Carsana A; Censier K; Fortunato G; Girard T; Heytens L; Hopkins PM; Jurkat-Rott K; Klinger W; Kozak-Ribbens G; Krivosic R; Monnier N; Nivoche Y; Olthoff D; Rueffert H; Sorrentino V; Tegazzin V; Mueller CR Eur J Hum Genet; 2003 Apr; 11(4):342-8. PubMed ID: 12700608 [TBL] [Abstract][Full Text] [Related]
3. [Current data on the screening of malignant hyperthermia during anesthesia]. Krivosic-Horber R; Adnet P Chirurgie; 1993-1994; 119(1-2):55-8. PubMed ID: 7995103 [TBL] [Abstract][Full Text] [Related]
5. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294 [TBL] [Abstract][Full Text] [Related]
6. Malignant hyperthermia: a review. Golinski M Plast Surg Nurs; 1995; 15(1):30-3, 58. PubMed ID: 7777624 [TBL] [Abstract][Full Text] [Related]
7. Increasing the number of diagnostic mutations in malignant hyperthermia. Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329 [TBL] [Abstract][Full Text] [Related]
8. [Current aspects of the diagnosis of malignant hyperthermia]. Rüffert H; Olthoff D; Deutrich C; Froster UG Anaesthesist; 2002 Nov; 51(11):904-13. PubMed ID: 12434264 [TBL] [Abstract][Full Text] [Related]
9. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia. Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia. Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621 [TBL] [Abstract][Full Text] [Related]
16. The genetics of malignant hyperthermia: evidence for heterogeneity. McPherson E; Taylor CA Am J Med Genet; 1982 Mar; 11(3):273-85. PubMed ID: 7081293 [TBL] [Abstract][Full Text] [Related]
17. Malignant hyperthermia in China. Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816 [TBL] [Abstract][Full Text] [Related]
18. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary]. Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536 [TBL] [Abstract][Full Text] [Related]